Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
Lose
G
G
Department of Obstetrics and Gynaecology, Glostrup County Hospital, University of Copenhagen, and Ferring Pharmaceuticals AB, Copenhagen, Denmark. ibon@glostruphosp.kbhamt.dk
Nørgaard
J P
JP
D000283:Administration, Intravesical; D002648:Child; D018680:Cholinergic Antagonists / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D008333:Mandelic Acids / Q000008:administration & dosage* / Q000493:pharmacokinetics; D013119:Spinal Cord Injuries / Q000150:complications; D016896:Treatment Outcome; D001745:Urinary Bladder Diseases / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D014549:Urinary Incontinence / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism
D018680:Cholinergic Antagonists; D008333:Mandelic Acids; C005419:oxybutynin